Announcement on Approval of Eslicarbazepine Acetate Tablets by the U.S. FDA

About this update from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

Announcement on Approval of Eslicarbazepine Acetate Tablets by the U.S. FDAThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Pharmaceuticals Holding Co. Ltd. Class A